Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 712 of 767

Advanced search

🌍Jul 10, 2024Mediablogs.nvidia.comTier 3 · Secondary coverage

Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI

PaigeOriginal source

🌍Jul 9, 2024Industryintercure.coTier 1 · Company source

InterCure Ltd. Announces Proposed VoluntaryDelisting from the Toronto Stock Exchangeand shallcontinue to be listed on the NASDAQ and TASE

InterCureOriginal source

🇪🇬Jul 9, 2024Researchcu.edu.egTier 2 · Direct publisher

Dr. Elkhosht: The Cairo University Journal of Veterinary Sciences and Medicine makes it into the golden zone of the best journals in the world for 2024 according to Scopus and Clarivate

Cairo UniversityOriginal source

🇺🇸Jul 9, 2024CDMOadarepharmasolutions.comTier 3 · Secondary coverage

Which Drug Delivery Technologies Should You Know About in 2024

Adare PharmaceuticalsOriginal source

🌍Jul 8, 2024Industrytrevena.comTier 1 · Company source

Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing

TrevenaOriginal source

🇪🇬Jul 6, 2024Researchcu.edu.egTier 2 · Direct publisher

Cairo University continues its global progress and ranks 260th globally in the Leiden Ranking 2024

Cairo UniversityOriginal source

🇺🇸Jul 1, 2024CDMOadarepharmasolutions.comTier 3 · Secondary coverage

Customized Release Through Dispersed Dosage Formats Driving Patient Acceptance and Therapeutic Performance

Adare PharmaceuticalsOriginal source

🌍Jun 25, 2024Mediahealx.aiTier 2 · Direct publisher

Remembering Dr. Neil T. Thompson

HealxOriginal source

🇺🇸Jun 25, 2024CDMOadarepharmasolutions.comTier 3 · Secondary coverage

Watch Now: The Importance Of An End-To-End CDMO

Adare PharmaceuticalsOriginal source

🇪🇬Jun 22, 2024Researchcu.edu.egTier 2 · Direct publisher

Following in the footsteps of the leaders of Arab thought: an Algerian thesis looks at Mohamed Othman Elkhosht the philosopher, his approach and the concept of enlightenment

Cairo UniversityOriginal source

🇪🇬Jun 22, 2024Researchcu.edu.egTier 2 · Direct publisher

Dr. Elkhosht receives a visit from the head of the African Scholars Forum and the head of the Islamic Cultural Association in Mauritania and West Africa; they discuss many issues related to renewing religious discourse

Cairo UniversityOriginal source

🌍Jun 21, 2024Industryperspective.comTier 1 · Company source

Perspective Shares CSO Placement Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍Jun 21, 2024Industrymaravai.comTier 1 · Company source

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

Maravai LifeSciencesOriginal source

🇺🇸Jun 21, 2024Devicesdanaher.comTier 1 · Company source

California Transparency in Supply Chains Act

Danaher Company NewsOriginal source

🌍Jun 20, 2024Industrytrevena.comTier 1 · Company source

Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models

TrevenaOriginal source

🌍Jun 20, 2024Industryonkuretherapeutics.comTier 1 · Company source

OnKure Announces the Appointment of Rogan Nunn, J.D., as General Counsel and Secretary

OnKure TherapeuticsOriginal source

🇪🇬Jun 15, 2024Researchcu.edu.egTier 2 · Direct publisher

Dr. Elkhosht welcomes a high-level delegation from Fudan University of China to Cairo International University (CIU)开罗大学校长Mohamed Elkhosht博士在开罗国际大学接待了由复旦大学校长金力博士率领的代表团访问。复旦大学被公认为国际排名较高的顶尖学府之一。

Cairo UniversityOriginal source

🇺🇸Jun 15, 2024CDMOadarepharmasolutions.comTier 3 · Secondary coverage

From Risk To Resolution: A Breakthrough in Nitrosamine Analysis & Mitigation

Adare PharmaceuticalsOriginal source

🇪🇬Jun 13, 2024Researchcu.edu.egTier 2 · Direct publisher

Dr.Elkhosht et l ambassadeur de France inaugurent le bureau national de l Agence Universitaire de la Francophonie à l Université internationale du Caire dans la ville du 6 octobre

Cairo UniversityOriginal source

🇪🇬Jun 13, 2024Researchcu.edu.egTier 2 · Direct publisher

Cairo University Continues Its Development Journey with the Release of the Third Sustainable Development Report

Cairo UniversityOriginal source

🇺🇸Jun 13, 2024CDMOnoramco.comTier 2 · Direct publisher

Diversifying the Supply of Raw Materials

NoramcoOriginal source

🌍Jun 4, 2024Mediabreakingcancernews.comTier 3 · Secondary coverage

From Humble Beginnings to A-List Cancer Fighter: Paige’s Remarkable Journey

PaigeOriginal source

🇮🇱May 30, 2024Devicesmedinol.comTier 1 · Company source

CE Approval for Medinol’s EluNIR-PERL™ Drug-Eluting Stent System

MedinolOriginal source

🇯🇵May 27, 2024Deviceshoya.comTier 1 · Company source

TCFD Disclosure updated in 2024

HOYA CorporationOriginal source

🇮🇱May 23, 2024Devicesmedinol.comTier 1 · Company source

Dr. Raj Dave of Cardiovascular Experts of PA implanted the EluNIR – PERL DES

MedinolOriginal source

🇮🇱May 23, 2024Devicesmedinol.comTier 1 · Company source

FDA Approves Early Feasibility Study for our Groundbreaking ChampioNIR™ Drug-Eluting Peripheral Stent System

MedinolOriginal source

🇮🇱May 23, 2024Devicesmedinol.comTier 1 · Company source

Clinical considerations during spontaneous coronary artery dissection in the post-partum period: a case report

MedinolOriginal source

🌍May 21, 2024Industrycytosorbents.comTier 1 · Company source

Unveiling the Impact of CytoSorb Therapy on Fluid Balance in Septic Shock Patients

CytosorbentsOriginal source

🌍May 15, 2024Industrytrevena.comTier 1 · Company source

Trevena Reports First Quarter 2024 Results and Provides Business Update

TrevenaOriginal source

🌍May 13, 2024Industryonkuretherapeutics.comTier 1 · Company source

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

OnKure TherapeuticsOriginal source

🇺🇸May 10, 2024Industrycapsida.comTier 1 · Company source

Capsida Biotherapeutics to Present Preclinical Data for Parkinson’s Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration

Capsida BiotherapeuticsOriginal source

🇺🇸May 10, 2024Researchnews.vcu.eduTier 2 · Direct publisher

10 innovative research projects earn latest funding from VCU’s Arts, Humanities and Social Sciences Fund

VCUOriginal source

🌍May 9, 2024Industryblueprintgenetics.comTier 1 · Company source

Sequencing services for Whole Genome and Whole Exome research use

Blueprint Genetics (Quest Diagnostics)Original source

🇺🇸May 7, 2024Industrycapsida.comTier 1 · Company source

Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations

Capsida BiotherapeuticsOriginal source

🇺🇸May 1, 2024CDMOveranex.comTier 2 · Direct publisher

Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific

VeranexOriginal source

🌍Apr 30, 2024Industryvirtualincision.comTier 1 · Company source

Virtual Incision Announces Publication of Data from its U.S. Investigational Device Exemption Study in the Clinical Journal, Diseases of Colon and Rectum

Virtual IncisionOriginal source

🇺🇰Apr 24, 2024CDMOquotientsciences.comTier 2 · Direct publisher

Quotient Sciences Wins 2024 CRO Leadership Awards

Quotient SciencesOriginal source

🌍Apr 16, 2024Mediapathologynews.comTier 3 · Secondary coverage